GLG Pharma
STAT3
STAT 3 inhibitors
STAT3 cancer
STAT3 inhibitors
Cancer
cancer diagnosis
STAT
cancer prevention
GLG-302 Selected by NCI for Funding in Cancer Prevent Program
GLG Pharma’s STAT3 Signaling Inhibitor Selected for NCI’s PREVENT Cancer Preclinical Drug Development Program.
...
Richard Gabriel
Wed, Jul 24, 2013 @ 12:45 PM
Comments